Contact this trialFirst, we need to learn more about you.
Sodium-glucose cotransporter 2 (SGLT2) inhibitor
Canagliflozin for Heart Disease
Recruiting1 awardPhase 2 & 3
Ottawa, Ontario
This trial is a small study to see if a medication called canagliflozin can reduce inflammation in the arteries of patients with heart disease. They will compare the effects of canaglif
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service